ID-5184 Wonca Abstracts supplement L-Z 13-10-23 - Flipbook - Page 49
WONCA 2023 Supplement 2: WONCA 2023 abstracts (L–Z)
L
M
N
O
P
Cardiometabolic health and determinants during pregnancy:
Results from the first year of the PROMOTE pilot study
Dr Ania Lucewicz Samarawickrama1,2,3, Sarah Melov1,4, Vicki Flood1,6, Wah Cheung1,7,8, Ben Smith1,9,
Tim Usherwood1,3, Justin McNab1,10, Judith Heads10,11, Joshua Ryan12, Yoon Ji Jina Rhou1,7,8,
Mark McLean7,8, Dharmintra Pasupathy1,4,5
1
Q
R
S
T
U
V
W
X
Y
Z
Reproduction and Perinatal Centre, Faculty of Medicine and Health, The University of Sydney,
MyHealth Medical Centre, Parramatta, 3Specialty of General Practice, Faculty of Medicine and Health,
The University of Sydney, 4Specialty of Obstetrics, Gynaecology and Neonatology, Westmead Clinical
School, The University of Sydney, 5Department of Women and Children’s, King’s College London,
6
University Centre for Rural Health, Northern Rivers Clinical School, The University of Sydney, 7Centre
for Diabetes and Endocrinology Research, Westmead Hospital, 8Specialty of Medicine, Westmead
Clinical School, The University of Sydney, 9Sydney School of Public Health, The University of Sydney,
10
Faculty of Medicine and Health, The University of Sydney, 11The Westmead Institute for Medical
Research, 12New South Wales Health Pathology
2
Background
A demographic shift among pregnant patients, including older age and increasing obesity, has
resulted in an increase in cardiometabolic complications during pregnancy and over the lifetime.
Lifestyle interventions during pregnancy have not yet produced clinically meaningful perinatal or longterm outcomes. There is an urgent need for high-quality observational data about cardiometabolic
health during pregnancy to identify subgroups at highest risk and to understand the interplay of clinical
and social determinants.
Methods
The PROMOTE pilot study is a prospective cohort study recruiting pregnant participants from a
highly diverse population in Western Sydney, Australia. Participants are surveyed about physical
activity levels, diet, emotional wellbeing and sociodemographic status. Participants are consented for
biobanking and the use of routinely collected data, including medical conditions, body mass index
(BMI), blood pressure (BP), glycaemia and perinatal outcomes. Outcomes include: the incidence of
non-communicable diseases during pregnancy, including gestational diabetes mellitus (GDM) and
hypertensive disorders of pregnancy (HDP). Postnatal and longitudinal outcomes are planned.
Results
During the first year, 235 participants were recruited in a socially/ethnically diverse population; 110 had
birthed. The recruitment rate was 90%. The mean maternal age was 31.88 years (range 21–43). Mean
gestational age was 12 weeks, 3 days (range 8–15). In all, 232 of 235 participants provided data on
physical activity; 33.62% demonstrated sufficient levels, 54.74% demonstrated insufficient levels and
11.64% were sedentary. This is similar to Australian national data, but well below recommendations.
The mean servings of fruit/week was 11.86 (range 0–42), vegetables 10.81 (range 0–35), fried food
1.64 (range 0–14), crisps 1.95 (range 0–14), soft drink 4.10 (range 0–35) and take-out food 1.65 (range
0–14). In all, 231 of 235 provided demographic data.
Conclusions
The first year of recruitment demonstrates high levels of acceptability, recruitment and reach. The
PROMOTE pilot study is well positioned to provide high-quality granular data about clinical/social
determinants of cardiometabolic risk in pregnancy and beyond.
47